European heart journal. Imaging methods and practice · 2026
Sex differences in photon-counting computed tomography findings across hypertrophic phenotypes.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
De Gori Carmelo, Aimo Alberto, Chen Yu Fu Ferrari, Pignatelli Francesca, Occhipinti Mariaelena, Muca Matilda, Zai Denisa Simona, Campora Alessandro, Castiglione Vincenzo, Barison Andrea, Poletti Roberta, Maffei Silvia, Clemente Alberto, Todiere Giancarlo, Vergaro Giuseppe, Emdin Michele
Аннотация
AIMS: Photon-counting computed tomography (PCCT) enables simultaneous assessment of left ventricular morphology, function, and myocardial tissue characterization. Whether sex influences PCCT findings across hypertrophic phenotypes remains uncertain.
METHODS AND RESULTS: We studied consecutive adults with a left ventricular hypertrophic phenotype undergoing PCCT. Patients were classified as hypertrophic cardiomyopathy (HCM), transthyretin amyloid cardiomyopathy (ATTR-CM), or secondary left ventricular hypertrophy (LVH). Sex differences in PCCT-derived left ventricular mass index, volumes, ejection fraction (EF), late iodine enhancement (LIE), and extracellular volume (ECV) were assessed overall and by aetiology. In patients with clinically indicated cardiovascular magnetic resonance (CMR) within ±12 months, sex effects on CT-CMR agreement were also evaluated. Among 182 patients, 50 were women and 132 were men; 83 had paired PCCT-CMR data. In the overall cohort, women had lower left ventricular mass index, smaller left ventricular volumes, higher EF, slightly lower ECV, and lower LIE extent than men. In HCM, women and men showed similar wall thickness, left ventricular mass, LIE burden, and ECV. In secondary LVH, women had smaller volumes and higher EF, without meaningful differences in tissue markers. In ATTR-CM, women appeared less remodelled and less infiltrative, although only four women were included. CT-CMR agreement for wall thickness, left ventricular mass, EF, scar extent, and ECV was similar in women and men. Diagnostic ECV thresholds were also consistent across sexes.
CONCLUSION: Sex influences PCCT hypertrophic phenotypes mainly through remodelling and functional adaptation rather than major differences in tissue characterization. CT-CMR agreement and diagnostic ECV thresholds appear robust across sexes.
METHODS AND RESULTS: We studied consecutive adults with a left ventricular hypertrophic phenotype undergoing PCCT. Patients were classified as hypertrophic cardiomyopathy (HCM), transthyretin amyloid cardiomyopathy (ATTR-CM), or secondary left ventricular hypertrophy (LVH). Sex differences in PCCT-derived left ventricular mass index, volumes, ejection fraction (EF), late iodine enhancement (LIE), and extracellular volume (ECV) were assessed overall and by aetiology. In patients with clinically indicated cardiovascular magnetic resonance (CMR) within ±12 months, sex effects on CT-CMR agreement were also evaluated. Among 182 patients, 50 were women and 132 were men; 83 had paired PCCT-CMR data. In the overall cohort, women had lower left ventricular mass index, smaller left ventricular volumes, higher EF, slightly lower ECV, and lower LIE extent than men. In HCM, women and men showed similar wall thickness, left ventricular mass, LIE burden, and ECV. In secondary LVH, women had smaller volumes and higher EF, without meaningful differences in tissue markers. In ATTR-CM, women appeared less remodelled and less infiltrative, although only four women were included. CT-CMR agreement for wall thickness, left ventricular mass, EF, scar extent, and ECV was similar in women and men. Diagnostic ECV thresholds were also consistent across sexes.
CONCLUSION: Sex influences PCCT hypertrophic phenotypes mainly through remodelling and functional adaptation rather than major differences in tissue characterization. CT-CMR agreement and diagnostic ECV thresholds appear robust across sexes.